Assessing blood pressure changes after bariatric surgery
Dynamics of Blood Pressure Changes After Bariatric Surgery, Assessed With 24-h Blood Pressure Monitoring
This study is testing how bariatric surgery affects blood pressure in people with obesity to see if losing weight can help lower their blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw, Mazowieckie) |
| Trial ID | NCT06460233 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the changes in blood pressure, cardiac function, and selected laboratory measurements in patients undergoing sleeve gastrectomy for obesity. It involves consecutive patients with class II or III obesity, who will undergo blood pressure monitoring, cardiac ultrasound, and laboratory tests before and after surgery at specified intervals. The study seeks to identify key factors associated with blood pressure reduction following weight loss, contributing to a better understanding of the relationship between obesity and hypertension.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with class II or III obesity (BMI ≥ 35 kg/m2 with comorbidities or BMI ≥ 40 kg/m2) who are scheduled for sleeve gastrectomy.
Not a fit: Patients who may not benefit from this study include those with psychiatric illnesses, previous bariatric surgery, severe gastroesophageal reflux disease, active neoplastic disease, pregnancy, or chronic arrhythmias.
Why it matters
Potential benefit: If successful, this study could provide insights into how weight loss from bariatric surgery can lead to significant improvements in blood pressure management for obese patients.
How similar studies have performed: Other studies have shown promising results in understanding the relationship between weight loss and blood pressure reduction, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI ≥40kg/m2 or ≥35 kg/m2 with comorbidities Exclusion Criteria: * Lack of informed consent * Expected lack of compliance * Psychiatric illness * Previous bariatric surgery * Severe gastroesophageal reflux disease * Active neoplastic disease * Pregnancy * Chronic atrial fibrillation or other persistent arrhythmia
Where this trial is running
Warsaw, Mazowieckie
- Central Warsaw Medical University Teaching Hospital — Warsaw, Mazowieckie, Poland (Recruiting)
Study contacts
- Principal investigator: Grzegorz Styczynski, MD, PhD — Medical University of Warsaw
- Study coordinator: Grzegorz Styczynski, MD, PhD
- Email: grzegorz.styczynski@wum.edu.pl
- Phone: 48 502851288
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.